These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25173805)

  • 1. Ghrelin: a link between ageing, metabolism and neurodegenerative disorders.
    Stoyanova II
    Neurobiol Dis; 2014 Dec; 72 Pt A():72-83. PubMed ID: 25173805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin and Neurodegenerative Disorders-a Review.
    Shi L; Du X; Jiang H; Xie J
    Mol Neurobiol; 2017 Mar; 54(2):1144-1155. PubMed ID: 26809582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of metabolism in neurodegenerative disorders.
    Procaccini C; Santopaolo M; Faicchia D; Colamatteo A; Formisano L; de Candia P; Galgani M; De Rosa V; Matarese G
    Metabolism; 2016 Sep; 65(9):1376-90. PubMed ID: 27506744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin and ghrelin: Sewing metabolism onto neurodegeneration.
    de Candia P; Matarese G
    Neuropharmacology; 2018 Jul; 136(Pt B):307-316. PubMed ID: 29248481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
    Beal MF
    Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
    Morgan AH; Rees DJ; Andrews ZB; Davies JS
    Neuropharmacology; 2018 Jul; 136(Pt B):317-326. PubMed ID: 29277488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease.
    Dos Santos VV; Rodrigues AL; De Lima TC; de Barioglio SR; Raisman-Vozari R; Prediger RD
    Curr Pharm Des; 2013; 19(38):6773-90. PubMed ID: 23530516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective properties of resveratrol and derivatives.
    Richard T; Pawlus AD; Iglésias ML; Pedrot E; Waffo-Teguo P; Mérillon JM; Monti JP
    Ann N Y Acad Sci; 2011 Jan; 1215():103-8. PubMed ID: 21261647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin and autophagy.
    Ezquerro S; Frühbeck G; Rodríguez A
    Curr Opin Clin Nutr Metab Care; 2017 Sep; 20(5):402-408. PubMed ID: 28590260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics of human brain aging and age-related neurodegenerative diseases.
    Jové M; Portero-Otín M; Naudí A; Ferrer I; Pamplona R
    J Neuropathol Exp Neurol; 2014 Jul; 73(7):640-57. PubMed ID: 24918636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins.
    Butterfield DA; Kanski J
    Mech Ageing Dev; 2001 Jul; 122(9):945-62. PubMed ID: 11348660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metabolism as a modulator of autophagy in neurodegeneration.
    Lim Y; Cho H; Kim EK
    Brain Res; 2016 Oct; 1649(Pt B):158-165. PubMed ID: 26970520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.